{
    "clinical_study": {
        "@rank": "146287", 
        "brief_summary": {
            "textblock": "To provide the IRB approved mechanism for the prospective collection, analysis and reporting\n      of data on patients who are undergoing either an autologous or allogeneic hematopoietic stem\n      cell transplant for a disease in which a research question is not being addressed and for\n      which peer reviewed, published data have demonstrated efficacy for this treatment approach."
        }, 
        "brief_title": "The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen", 
        "completion_date": {
            "#text": "May 2018", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Acute Myelogenous Leukemia", 
            "Acute Lymphocytic Leukemia", 
            "Chronic Myelogenous Leukemia", 
            "Non-Hodgkin's Lymphoma", 
            "Hodgkin's Disease", 
            "Multiple Myeloma", 
            "Germ Cell Neoplasms", 
            "Myelodysplastic Syndromes", 
            "Chronic Lymphocytic Leukemia", 
            "Immunodeficiency Diseases"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Hodgkin Disease", 
                "Immunologic Deficiency Syndromes", 
                "Leukemia", 
                "Leukemia, Lymphocytic, Chronic, B-Cell", 
                "Leukemia, Lymphoid", 
                "Precursor Cell Lymphoblastic Leukemia-Lymphoma", 
                "Leukemia, Myeloid, Acute", 
                "Leukemia, Myeloid", 
                "Leukemia, Myelogenous, Chronic, BCR-ABL Positive", 
                "Lymphoma", 
                "Lymphoma, Non-Hodgkin", 
                "Multiple Myeloma", 
                "Neoplasms, Plasma Cell", 
                "Myelodysplastic Syndromes", 
                "Preleukemia", 
                "Neoplasms, Germ Cell and Embryonal"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Planned standard of care dose intensive therapy and either an allogeneic or autologous\n        bone marrow transplant\n\n        Exclusion Criteria:\n\n        participation in any other treatment research protocol"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "patients who are not on a specific \"treatment research protocol\" but who are nevertheless\n        receiving \"standard of care\" dose intensive therapy and either an allogeneic or autologous\n        bone marrow transplant"
            }
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01890486", 
            "org_study_id": "CCCWFU 95300"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 3, 2014", 
        "location": {
            "contact": {
                "email": "dhurd@wakehealth.edu", 
                "last_name": "David Hurd, MD", 
                "phone": "336-716-2843"
            }, 
            "facility": {
                "address": {
                    "city": "Winston-Salem", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27157"
                }, 
                "name": "Wake Forest Baptist Health"
            }, 
            "investigator": {
                "last_name": "David Hurd, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Gather basic survival and complication data for operational and research databases for ongoing  regulatory and futre operational queries", 
            "measure": "Data followup", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01890486"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Comprehensive Cancer Center of Wake Forest University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Comprehensive Cancer Center of Wake Forest University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2001", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "1 Year", 
        "verification_date": "January 2014"
    }
}